Committee on Clinical Pharmacology and Pharmacogenomics
Welcome to the Committee on Clinical Pharmacology and Pharmacogenomics
The Clinical Pharmacology and Pharmacogenomics Training Program is sponsored in part by the National Institutes of Health (NIH) along with the University of Chicago Biological Sciences Division and the University of Chicago Cancer Research Foundation Women’s Board.
Eligible individuals must have a:
- MD, MD/PhD, PharmD or PhD degree
- be a citizen or permanent resident of the United States
- complete residency training (MD and PharmD applicants)
The program is on a rolling submission but it is highly recommended applications are submitted at least six (6) months prior to desired start date.
To apply for the CCPP program, an individual must complete the following:
- Online application [CLICK HERE]
- Career Interest Summary (attachment within the application)
Instructions: Complete a 1 – 2 page summary of your interest in clinical pharmacology and pharmacogenomics and your future career plans. Include information regarding any training in teaching or research.
- Curriculum Vitae (attachment within the application)
- One to three Letters of Recommendation depending on internal vs external candidates (sent separately)
Instructions: Recommendation letters must: 1) be on institutional letterhead with an original signature, 2) are accepted via email to Lexi Nash Smith, email@example.com, 3) be addressed to Dr. Peter H. O’Donnell, Chair Committee on Clinical Pharmacology, and Pharmacogenomics. Applicants are responsible for following up with recommenders. Applications are not considered completed until all material is received.Program Address:
The University of Chicago
5841 S. Maryland Ave, MC 2115
Chicago, IL 60637
Attn: Lexi Nash Smith
Applications from non-US citizen within the United States are accepted. Funding is limited. Other training opportunities for non-US citizens can be found through the Office of Global Health at the University of Chicago.
The University of Chicago community is committed to an environment conducive to learning, teaching, working and conducting research that values diversity. We welcome all individuals who come from diverse populations that are under-represented in science or academia including but not limited to racial and ethnic minorities, individuals from disadvantaged socio-economic backgrounds and individuals with disabilities. Program faculty coordinate with the The University of Chicago Office of Diversity & Inclusion to continually improve recruitment, retention, scholarship, leadership, and mentorship of qualified students, staff, and faculty in an environment rich with cultural awareness, and sensitivity.
Explore our Programs
CCPP offers the NIH-funded training program which provides comprehensive training program for qualified post-doctoral individuals.
CCPP offers disciplines such as novel drug development, therapeutic molecular science, immunology, pharmaco-genomics, and therapeutic toxicity mitigation.
Our training program offers various training that fits your career goals. All trainees are eligible for certification in Clinical Pharmacology through the American Board of Clinical Pharmacology.
Our program trains post-docs enter into careers in academia, industry, government, or clinical practice.
“It is my great pleasure to serve as Chair of the Committee on Clinical Pharmacology and Pharmacogenomics at the University of Chicago and to welcome your interest in our program!
The University of Chicago Fellowship Program in Clinical Pharmacology and Pharmacogenomics offers a world-class training opportunity to qualified post-doctoral individuals (MD, PharmD, PhDs) who wish to acquire advanced expertise in clinical therapeutics — including disciplines such as novel drug development, therapeutic molecular science, immunology, pharmacogenomics, pharmacoeconomics, and therapeutic toxicity mitigation, among many others.
For over 45 years, we have offered this NIH-funded training program – one of only a few such programs in the United States. Our fellowship training brings together individuals like you – curious, early career scientists from diverse skillsets and backgrounds – with our unparalleled Committee faculty who are international experts in their respective research fields, to ask and inspire the next frontier of research questions that will inform discovery and improved use of medical therapies.
Chair’s Welcome Video
Chair, Peter H. O’Donnell, MD
In this video, the Chair of the Committee of Pharmacology and Pharmacogenomics (CCPP) introduces the history of the committee, the training opportunity that CCPP offers, and several reasons why eligible graduate students should apply for our program.
Past Trainee Feedback
I’m really grateful for the opportunities that I’ve been given in this fellowship and I think it will really allow me to reach the career goals that I’m hoping for in the long run.
Jason Budno, PharmD, PhD
“The ability to collaborate with and work alongside PharmDs, PhDs, and other MDs outside my specialty was not only really nice but also broadened and enlightened my approach to medicine and patient care as a whole.”
“In addition to research, it [the CCPP Committee] provides a very well organized training program which covers all areas of clinical pharmacology therapeutics and pharmacogenomics.“
The Committee on Clinical Pharmacology and Pharmacogenomics has ongoing collaborations with various credible organizations, such as University of Chicago Personalized Therapeutics Clinic and American Board of Clinical Pharmacology.
Clinical Pharmacology Boards
Our training program is accredited by the American Board of Clinical Pharmacology (ABCP) which was established with the cooperation of the American College of Clinical Pharmacology, the American Society for Clinical Pharmacology and Therapeutics, and the American Society for Pharmacology and Experimental Therapeutics.
For further information visit: www.abcp.net
If you possess further inquiries or require specific information regarding the program, we kindly request that you direct your communication to the committee through the designated email channel. Email transmitted via this medium will be promptly directed to the Program Administrator.